Anterogen Co (XKRX:065660) FCF Margin % : -28.86% (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Anterogen Co's Free Cash Flow for the three months ended in Dec. 2024 was ₩-516 Mil. Anterogen Co's Revenue for the three months ended in Dec. 2024 was ₩1,788 Mil. Therefore, Anterogen Co's FCF Margin % for the quarter that ended in Dec. 2024 was -28.86%.

As of today, Anterogen Co's current FCF Yield % is -0.58%.

The historical rank and industry rank for Anterogen Co's FCF Margin % or its related term are showing as below:

XKRX:065660' s FCF Margin % Range Over the Past 10 Years
Min: -244.54 Med: -66.76 Max: 5.25
Current: -16.9

During the past 11 years, the highest FCF Margin % of Anterogen Co was 5.25%. The lowest was -244.54%. And the median was -66.76%.

XKRX:065660's FCF Margin % is ranked better than
67.07% of 999 companies
in the Biotechnology industry
Industry Median: -116.7 vs XKRX:065660: -16.90

Anterogen Co FCF Margin % Historical Data

The historical data trend for Anterogen Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co FCF Margin % Chart

Anterogen Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-244.54

-81.08

-52.44

-33.71

-16.90

Anterogen Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															7.91	-15.07	29.08	-48.48	-28.86

Competitive Comparison of Anterogen Co's FCF Margin %

For the Biotechnology subindustry, Anterogen Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anterogen Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anterogen Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Anterogen Co's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Anterogen Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Anterogen Co's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-1171.967	/	6932.865
	=	-16.90 %

Anterogen Co's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-515.936	/	1787.713
	=	-28.86 %

Anterogen Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Anterogen Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Anterogen Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589

Website

http://www.anterogen.com

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co Headlines

No Headlines